This article has Open Peer Review reports available.
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
- Rebecca M. Reynolds†1, 2Email author,
- Fiona C. Denison†1, 2,
- Ed Juszczak3,
- Jennifer L. Bell3,
- Jessica Penneycard2,
- Mark W. J. Strachan4,
- Robert S. Lindsay5,
- Claire I. Alexander6,
- Corinne D. B. Love6,
- Sonia Whyte2,
- Fiona Mackenzie5,
- Ben Stenson7 and
- Jane E. Norman2
© The Author(s). 2017
Received: 14 November 2016
Accepted: 11 September 2017
Published: 22 September 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|14 Nov 2016||Submitted||Original manuscript|
|16 May 2017||Reviewed||Reviewer Report - Yashdeep Gupta|
|27 May 2017||Reviewed||Reviewer Report - Sara Meltzer|
|28 Jul 2017||Author responded||Author comments - Rebecca Reynolds|
|Resubmission - Version 2|
|28 Jul 2017||Submitted||Manuscript version 2|
|8 Sep 2017||Author responded||Author comments - Rebecca Reynolds|
|Resubmission - Version 3|
|8 Sep 2017||Submitted||Manuscript version 3|
|11 Sep 2017||Editorially accepted|
|22 Sep 2017||Article published||10.1186/s12884-017-1505-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.